Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bu-Shen-An-Tai Recipe (BSATR), also known as Bushenantai or the modified Bushen Antai recipe (BSAT), is a traditional Chinese medicine (TCM) herbal formula used primarily to support pregnancy and prevent miscarriage. It is composed of multiple medicinal herbs and has been used for centuries in China. Preclinical studies indicate that it improves endometrial morphology during peri-implantation by increasing endometrial thickness, microvessel density (MVD), and pinopode formation[1]. In animal models of pregnancy loss induced by mifepristone or ovarian dysfunction, the recipe upregulates estrogen receptor alpha and progesterone receptor expression at the maternal-fetal interface[2][3], increases placental development markers such as Ki67 and phospho-Akt/AKT[2], inhibits apoptosis in ovarian granulosa cells via upregulation of Bcl-2 protein expression[4], and may modulate inflammatory pathways related to pyroptosis[6]. The formula is most commonly indicated for threatened abortion/pregnancy loss but may also be used in infertility associated with "kidney deficiency" patterns per TCM theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bu-Shen-An-Tai Recipe.